Report cover image

Nasal Vaccines: Global Markets and Pipeline Analysis

Publisher BCC Research
Published Dec 28, 2022
Length 78 Pages
SKU # WA17580967

Description

Nasal Vaccines: Global Markets and Pipeline Analysis

Report Scope:

This report examines trends and sales in the global market for nasal vaccines through 2027. Leaders in the industry and their vaccine portfolios, the need for nasal vaccine development, competitive intelligence and regional trends are discussed. The report includes a PESTEL analysis, that forms in part the base data for qualitative analysis and market estimates.

The report examines all forms of nasal vaccines, such as nasal drops or sprays, but excludes intramuscular and oral vaccines. The report discusses nasal vaccines by type, such as live-attenuated, inactivated, protein subunit and viral vectors. The application areas covered include pediatric and adult. Primary care clinics, hospitals, pharmacies and others are the end-user segments covered.

Report Includes:

23 data tables and 27 additional tables

A comprehensive overview and up-to-date analysis of the global market for nasal vaccines

Analyses of the global market trends, with historic market revenue data (sales figures) for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the upcoming market opportunities and trends driving and restricting growth of the global nasal vaccines market and its sub-segments, and the major regions and countries involved in market developments

Estimation of the actual market size and revenue forecast for the global nasal vaccines market in USD millions, and its corresponding market share analysis by vaccine type, dosage form, patient group, end-user, and region

Discussion of new developments in the nasal vaccines market, underlying clinical trials for all phases and list of vaccines, and their regulatory approvals etc.

Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues

Review of the new announcements, approvals, FDA clearances, partnerships and collaborations in the global nasal vaccines market

Detailed company profiles of the leading industry players, including AstraZeneca plc, BioDiem Ltd., BlueWillow Biologics, Meissa Vaccines Inc., and Serum Institute of India Pvt., Ltd.

Companies Mentioned

ASTRAZENECA PLC
BHARAT BIOTECH INTERNATIONAL LTD.
BioDiem Ltd.
BLUEWILLOW BIOLOGICS INC.
CHANGCHUN BCHT BIOTECHNOLOGY CO.
CODAGENIX INC.
CYANVAC LLC
INTRAVACC LLC
MEISSA VACCINES INC.
RAZI VACCINE AND SERUM RESEARCH INSTITUTE
SERUM INSTITUTE OF INDIA PVT. LTD.

Table of Contents

78 Pages
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst's Credentials
1.8 BCC Custom Research
1.9 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Nasal Immune Response
3.2 Benefits of Developing Nasal Vaccines
3.3 Market Drivers
3.3.1 Rising Incidence of Respiratory Infections
3.3.2 Cost-Effective Alternative to Mainstream Vaccines
3.3.3 Increased Government Support and Favorable Regulations
3.3.4 Rising Awareness of the Need for Vaccination Programs
3.3.5 R&D for Nasal Vaccines
3.4 Market Restraints
3.4.1 Limited Immunization in Low- and Middle-Income Countries
3.4.2 Technical Drawbacks of Nasal Vaccines
3.5 Market Opportunities
3.5.1 Demand for Innovative Approaches to Combat COVID-19
3.6 PESTEL Analysis
3.7 Reimbursement Scenarios
3.8 Impact of COVID-19 on the Market for Nasal Vaccines
Chapter 4 Pipeline Analysis of Nasal Vaccines
4.1 Nasal Vaccine Product Pipeline
4.1.1 Product Pipeline, by Clinical Trial Phase
4.1.2 Product Pipeline, by Disease
4.1.3 Product Pipeline, by Vaccine Type
Chapter 5 Global Market for Nasal Vaccines by Type
5.1 Live-Attenuated Vaccines
5.2 Inactivated Vaccines
5.3 Viral Vector Vaccines
5.4 Protein Subunit Vaccines
Chapter 6 Global Market for Nasal Vaccines by Dosage Form
6.1 Nasal Sprays
6.2 Nasal Drops
6.3 Nasal Powders
6.4 Nasal Gels
Chapter 7 Global Market for Nasal Vaccines by Patient Group
7.1 Pediatric
7.2 Adult
Chapter 8 Global Market for Nasal Vaccines by End User
8.1 Primary Care Clinics
8.2 Hospitals
8.3 Pharmacies
8.4 Other End Users
Chapter 9 Global Market for Nasal Vaccines by Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World (RoW)
Chapter 10 Competitive Landscape
10.1 Announcements
10.2 Drug Approvals
10.3 Partnerships and Collaborations
Chapter 11 Company Profiles
ASTRAZENECA PLC
BHARAT BIOTECH INTERNATIONAL LTD.
BIODIEM LTD.
BLUEWILLOW BIOLOGICS INC.
CODAGENIX INC.
CHANGCHUN BCHT BIOTECHNOLOGY CO.
CYANVAC LLC
INTRAVACC LLC
MEISSA VACCINES INC.
RAZI VACCINE AND SERUM RESEARCH INSTITUTE
SERUM INSTITUTE OF INDIA PVT. LTD.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us